Neuro42 last raised $15.6M in its Early Stage VC (Sep 2024).
- ·The complete investor list: 12 names
- ·Watch Neuro42: the Monday email on marks, rounds and moves
Neuro42 funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Sep 2024 | Early Stage VC | $15.6M | ▮ | ▮ |
| May 2024 | Early Stage VC | $6.7M | ▮ | ▮ |
Membership and data by Private Market View
Neuro42 valuation
Neuro42's last known valuation is $135 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How much has Neuro42 raised?
Neuro42 has raised $30 million in total; 2 of its rounds are on record. The largest on record was a $6.7 million early-stage round in May 2024; the most recent was a $15.6 million early-stage round in Sep 2024.
Neuro42 has filed 2 Form Ds with the SEC, most recently in Sep 2024 ($15.6 million sold to 85 investors).
How Neuro42's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Neuro42, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Neuro42
- What is Neuro42 worth?
- Neuro42's last known valuation is $135.0M.
- How much has Neuro42 raised?
- Neuro42 has raised $30.0M in total funding across 2 recorded rounds.
- When did Neuro42 last raise?
- Neuro42 last raised in Sep 2024 (Early Stage VC), raising $15.6M.